Cure& Pharma, Inc.

> Financials > Income Statement

In Millions of the reported currency, except per share items.

Income Statement 12 months 12 months 12 months

For the Fiscal Period Ending Dec-31-2015 Dec-31-2016 Dec-31-2017
Currency (Millions) USD USD USD

Revenue 680.60 727.30 767.00

Other Revenue 116.7 120.8 142.2
Total Revenue 797.30 848.10 909.20

Cost Of Goods Sold 91.90 106.20 120.70

Gross Profit 705.40 741.90 788.40

Selling General & Admin Exp. 156.50 144.40 143.40

R & D Exp. 149.10 146.20 166.90
Depreciation & Amort. - - -
Amort. of Goodwill and Intangibles 28.30 27.70 33.70
Other Operating Expense/(Income) - 0.80 8.30

Other Operating Exp., Total 334.00 319.00 352.40

Operating Income 371.50 422.90 436.00

Interest Expense -7.10 -19.30 -18.60

Interest and Invest. Income 1.6 4.7 5.8
Net Interest Exp. -5.4 -14.6 -12.8

Income/(Loss) from Affiliates -0.9

Currency Exchange Gains (Loss) -2.4 -0.7 0.5
Other Non-Operating Inc. (Exp.) -1 -1.1 -0.9
EBT Excl. Unusual Items 361.70 406.50 422.80

Restructuring Charges -6.9 -5.8 -0.1

Merger & Related Restruct. Charges - - -
Impairment of Goodwill - - -
Gain (Loss) On Sale Of Invest. -0.30 0.4 -2.7
Gain (Loss) On Sale Of Assets - - -
Asset Writedown - -0.90 -26.60
In Process R & D Exp. - - -8.9
Legal Settlements - -33.70 -
Other Unusual Items -2.30 -1.10 -4.60
EBT Incl. Unusual Items 352.20 365.40 379.90

Income Tax Expense 86 91.7 182.1

Earnings from Cont. Ops. 266.2 273.8 197.8

Earnings of Discontinued Ops. - - -

Extraord. Item & Account. Change - - -
Net Income to Company 266.2 273.8 197.8

Minority Int. in Earnings -3.40 0.50 -9.70

Net Income 262.70 274.30 188.10
38.60 37.71 24.52
 12 months 12 months 12 months
Dec-31-2018 Dec-31-2019 Mar-31-2020
USD USD USD

806.40 842.90 859.60

190.10 222.10 208.70
996.50 1,065.00 1,068.30

134.50 144.80 133.90

862.00 920.20 934.40

156.20 175.30 175.50

192.40 167.80 161.30
- - -
28.20 20.30 20.50
13.7 17.90 18.9

390.60 381.30 376.20

471.40 538.90 558.20

-14.90 -13.90 -13.60

8.3 8.9 8.4
-6.5 -5.00 -5.20

-5.9 -4.9
-0.70 -0.50 -1.8
-0.6 -3.30 -3.60
463.60 524.20 542.70

-0.90 -0.10 -0.10

- -1.90 -1.9
- - -
8.9 15.20 -18.40
- -4.10 4.5
-27.10 -16.00 -16.00
-8.3 - -75
- - -
0.90 4.70 5.90
437.00 522.00 511.10

105.6 85.8 76.1

331.4 436.2 435

- - -
- - -
331.40 436.2 435

-3.20 0.50
328.20 436.20 435.50
40.70 51.75 50.66
Revenue by Product Product Revenue By Region
Product Revenue % of Revenue Region % of Revenue
PPH & Boosters 461 43.14% US 60.30%
Influenza 356 33.33% Others 39.70%
Meningitis 126 11.76%
Others 126 11.76%
1068.3